Tentarix Biotherapeutics’ Post

🌱🍽️ A sweet treat from our very own co-op garden! Our talented Research Associate, Jenna Angeles, crafted these amazing passion fruit tarts using the fruit grown right outside our lab. At Tentarix, we’re passionate about science—and delicious desserts! #GardenToLab

Introducing Dr. Andrew D. Kidd, the new Chief Executive Officer of Tentarix Biotherapeutics. With a rich history of leadership in biotechnology, Andy is poised to propel Tentarix forward to transform the landscape of precision oncology and immunology! Click here for more: https://lnkd.in/gBxaeetC

🐙 Go Team Tentarix! 🐙 Tentarix Biotherapeutics is stepping into the arena of the Fierce Biotech Best Name in Biotech Tournament, proudly seeded #1 in the Folklore / Animals division! Our innovative name, mirroring the precision and intelligence of our molecular designs, makes us a strong contender to go all the way. Support Tentarix by casting your vote today: https://lnkd.in/gK-SkPa2 #TentarixBiotherapeutics #BiotechBracket

Tentarix is #Hiring! We are looking to expand our growing San Diego team! Dive in for more information: https://lnkd.in/gF57EJP8

Exciting news: Tentarix and AbbVie are joining forces to potentially revolutionize oncology and immunology treatment through conditionally-active multi-specific biologics. Read more about our groundbreaking collaboration: https://lnkd.in/gn2_DhiW